A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...

OU Health has become the first health system in Oklahoma to use Cytalux, a groundbreaking technology that helps detect cancer cells during surgery.

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that the first patient has been tested for eligibility with the ...

Smoking leads to cancer. That's known. But what new research shows is quitting smoking soon after a diagnosis helps patients ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of a ...

“This discovery opens up a new avenue for cancer treatment,” Dr. Ankit Bharat ... and we specifically saw a response with ...

Press Release4BIO Capital Portfolio Company Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ...

AstraZeneca has announced data that it says will establish its lung cancer drug Tagrisso as ... slowed tumour progression compared with standard chemotherapy and was also more effective in ...

EMA committee recommends approval of Bristol Myers’ repotrectinib to treat advanced ROS1-positive NSCLC & NTRK-positive solid tumours: Princeton, New Jersey Monday, November 18, ...

Faced with a diagnosis of an incurable, life-threatening condition, for some the answer to their prayers can come in the form ...